These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2008-006439-12||Momento Estratégico para el Inicio de la Terapia Antiretroviral Strategic Timing of AntiRetroviral Treatment (START)||not-yet-due|
|Reported results||2014-004271-22||Anti-Influenza Hyperimmune Intravenous Immunoglobulin Clinical Outcome Study (INSIGHT 006: FLU-IVIG)||2018-07-02||due-trials|
|Listed as ongoing, but also has a completion date and reported results||2020-001052-18||A Multicenter, Adaptive, Randomised Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults - Version for European Unio...||2020-09-10||bad-data|
|Other||2020-002542-16||An International Multicenter, Adaptive, Randomized Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Tr...||not-yet-due|
|Other||2020-003278-37||A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients with COVID-19||not-yet-due|